These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 30951818

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Biofilm Eradication Four-Step Strategy: Study of Using Self-Assembled Azithromycin/Rhamnolipid Nanoparticles for Removing Pseudomonas aeruginosa Biofilm].
    Dong YT, Li PY, Sun YY, Rao YQ, Yu SH, Hu HY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):598-604. PubMed ID: 34323037
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Gisbert JP, Gonzalez L, Calvet X.
    Helicobacter; 2005 Jun; 10(3):157-71. PubMed ID: 15904473
    [Abstract] [Full Text] [Related]

  • 27. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
    Sheu BS, Wu JJ, Yang HB, Huang AH, Lin XZ.
    J Formos Med Assoc; 1998 Apr; 97(4):266-70. PubMed ID: 9585678
    [Abstract] [Full Text] [Related]

  • 28. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
    Furuta T, Shirai N, Xiao F, Takashita M, Sugimoto M, Kajimura M, Ohashi K, Ishizaki T.
    Hepatogastroenterology; 2003 Apr; 50(54):2274-8. PubMed ID: 14696516
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
    Huang AH, Sheu BS, Yang HB, Huang CC, Wu JJ, Lin XZ.
    J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P, Zhou LY, Xiao XM, Luo Y, Ding Y.
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.